Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2005 2
2006 1
2008 1
2009 2
2010 2
2011 1
2012 2
2013 3
2014 4
2015 3
2016 2
2017 6
2018 2
2019 3
2020 4
2021 6
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

41 results
Results by year
Filters applied: . Clear all
Page 1
27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology.
Nelson ER, Wardell SE, Jasper JS, Park S, Suchindran S, Howe MK, Carver NJ, Pillai RV, Sullivan PM, Sondhi V, Umetani M, Geradts J, McDonnell DP. Nelson ER, et al. Among authors: wardell se. Science. 2013 Nov 29;342(6162):1094-8. doi: 10.1126/science.1241908. Science. 2013. PMID: 24288332 Free PMC article.
Targeting mutant estrogen receptors.
Wardell SE, Norris JD, McDonnell DP. Wardell SE, et al. Elife. 2019 Jan 16;8:e44181. doi: 10.7554/eLife.44181. Elife. 2019. PMID: 30648967 Free PMC article.
Next-Generation Endocrine Therapies for Breast Cancer.
McDonnell DP, Wardell SE, Chang CY, Norris JD. McDonnell DP, et al. Among authors: wardell se. J Clin Oncol. 2021 Apr 20;39(12):1383-1388. doi: 10.1200/JCO.20.03565. Epub 2021 Mar 11. J Clin Oncol. 2021. PMID: 33705209 No abstract available.
Correction to: Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy.
Wardell SE, Yllanes AP, Chao CA, Bae Y, Andreano KJ, Desautels TK, Heetderks KA, Blitzer JT, Norris JD, McDonnell DP. Wardell SE, et al. Breast Cancer Res Treat. 2020 Feb;179(3):769. doi: 10.1007/s10549-019-05498-0. Breast Cancer Res Treat. 2020. PMID: 31734822 Free PMC article.
International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors.
Lu NZ, Wardell SE, Burnstein KL, Defranco D, Fuller PJ, Giguere V, Hochberg RB, McKay L, Renoir JM, Weigel NL, Wilson EM, McDonnell DP, Cidlowski JA. Lu NZ, et al. Among authors: wardell se. Pharmacol Rev. 2006 Dec;58(4):782-97. doi: 10.1124/pr.58.4.9. Pharmacol Rev. 2006. PMID: 17132855 Review. No abstract available.
41 results